News & Articles

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

Explore topics such as UV-Vis spectroscopy, DNA and RNA quantification, pediatric diagnostics and COVID-19 serology testing

Explore topics from single-cell RNA sequencing sample preparation and precise weighing processes to COVID-19 serology testing and pediatric diagnostics

Can a healthy lifestyle combat undernutrition and dementia?

The partnership aims to provide accessible solutions for labs involved in COVID-19 testing

A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster

SelectScience speaks with Integrated DNA Technologies (IDT) to hear how the company has been able to increase its offering of customizable and robust nucleic acid products to support the life science industry

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality

In this guest editorial, discover how genome editing in iPSCs can be a powerful tool to investigate the intricacies of the human genome

Assay automation from Beckman Coulter Life Sciences and Illumina makes cutting-edge research more accessible to labs

EMBER500™ RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels

the VOYAGER pipette range is generating more data in less time for HIV researchers

Under the new agreement, unique SAGAsafe dPCR assays will be developed for the analysis of tissue samples and liquid biopsies

OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively

Horizon Discovery has announced a new B cell screening service to support the development of therapeutics for immune system diseases